Risky Buy Oncimmune Holdings (ONC) by Kirsteen Mackay in The Motley Fool CLOSED
-
Performance
-91.48%
-
Price at start
189.00p
(ask)
-
Price at close
16.10p
(bid)
-
Tip made
13/10/2020
-
Tip Status
Closed
16/10/2023
Icon Key:
Tip Notes
"...The early diagnosis of cancer is vital in achieving a positive outcome, which makes it a lucrative area to be involved in, aside from its pandemic play. However, as a micro-cap listed on AIM, it still remains a risky buy. I’d add it to a contrarian portfolio of well-diversified stocks." - Kirsteen Mackay, The Motley FoolNOTE: Stockomendation Ltd is not responsible for any content contained on the page behind the link. Some tip search links need accounts or subscriptions with third parties in order to view the tip.